3D-QSAR analysis of anti-cancer agents by CoMFA and CoMSIA

被引:13
|
作者
Pourbasheer, Eslam [1 ,2 ,3 ]
Amanlou, Massoud [2 ,3 ]
机构
[1] Payame Noor Univ, Dept Chem, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Pharm & Drug Design, Dept Med Chem, Tehran, Iran
[3] Univ Tehran Med Sci, Res Dev Ctr, Tehran, Iran
关键词
3D-QSAR; CoMFA; CoMSIA; Anti-cancer; Drug design; QUANTITATIVE STRUCTURE; ANALOGS; QSAR; CYTOTOXICITY; SERIES; DERIVATIVES; INHIBITORS;
D O I
10.1007/s00044-013-0676-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three-dimensional quantitative structure-activity relationships were performed for a series of isatin derivatives as anti-cancer agents using the CoMFA and CoMSIA methods. Statistically significant CoMFA (r(cv)(2) - 0: 869; r(ncv)(2) - 0: 962) and CoMSIA (r(cv)(2) - 0: 865; r(ncv)(2) - 0: 959) models were generated using the training set on the basis of the common substructure-based alignment. Further, the predictive ability of the CoMFA and CoMSIA models was determined using a test set of nine compounds. Based on the information derived from CoMFA and CoMSIA contour maps, we have identified some key features for increasing the activity of compounds and have been used to design new anti-cancer agents. The newly designed molecules in this series of compounds may be more potent anti-cancer agents.
引用
收藏
页码:800 / 809
页数:10
相关论文
共 50 条
  • [31] 3D-QSAR study on VEGFR kinase inhibition of aminopyrazolopyridine urea derivatives by CoMFA and CoMSIA
    Atabati, Morteza
    Sharifi, Sudabeh
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (07) : 3539 - 3545
  • [32] Genetic algorithm for CoMFA setting optimization: 3D-QSAR study on α-aminosuberic acid derivatives as anti-cancer compounds
    Ebrahimi, S.
    Azimi, G.
    Akhlaghi, Y.
    Kompany-Zareh, M.
    JOURNAL OF CHEMOMETRICS, 2013, 27 (10) : 323 - 329
  • [33] 3D-QSAR study on atmospheric half-lives of POPs using CoMFA and CoMSIA
    Lv Yuyin
    Yin Chunsheng
    Liu Hongyan
    Yi Zhongsheng
    Wang Yang
    JOURNAL OF ENVIRONMENTAL SCIENCES, 2008, 20 (12) : 1433 - 1438
  • [34] 3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA
    Juan Zeng
    Guixia Liu
    Yun Tang
    Hualiang Jiang
    Journal of Molecular Modeling, 2007, 13 : 993 - 1000
  • [35] 3D-QSAR COMFA AND COMSIA ON PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORS
    Shukla, Vipasha
    Gupta, Swati
    Saxena, Anil K.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S147 - S147
  • [36] 3D-QSAR studies on fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA
    Zeng, Juan
    Liu, Guixia
    Tang, Yun
    Jiang, Hualiang
    JOURNAL OF MOLECULAR MODELING, 2007, 13 (09) : 993 - 1000
  • [37] 3D-QSAR study on VEGFR kinase inhibition of aminopyrazolopyridine urea derivatives by CoMFA and CoMSIA
    Morteza Atabati
    Sudabeh Sharifi
    Medicinal Chemistry Research, 2014, 23 : 3539 - 3545
  • [38] 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors
    Dessalew, Nigus
    Singh, Sanjeev Kumar
    MEDICINAL CHEMISTRY, 2008, 4 (04) : 313 - 321
  • [39] 2D and 3D-QSAR Analysis of Pyrazole-Thiazolinone Derivatives as EGFR Kinase Inhibitors by CoMFA and CoMSIA
    Pourbasheer, Eslam
    Aalizadeh, Reza
    Shiri, Hamid Mohammad
    Banaei, Alireza
    Ganjali, Mohammad Reza
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2015, 11 (04) : 292 - 303
  • [40] 3D-QSAR CoMFA/CoMSIA studies on urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents
    Bhongade, BA
    Gadad, AK
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (10) : 2797 - 2805